The Impact of Acute Kidney Injury on the Risk of Mortality and Health Care Utilization Among Patients Treated With Polymyxins for Severe Gram-Negative Infections

article

The Impact of Acute Kidney Injury on the Risk of Mortality and Health Care Utilization Among Patients Treated With Polymyxins for Severe Gram-Negative Infections is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/OFID/OFY191
P932PMC publication ID6114194
P698PubMed publication ID30182031

P2093author name stringKatelyn R Keyloun
Ryan N Hansen
Beth Devine
Patrick J Gillard
Douglas J Black
Sarah Baradaran
P2860cites workCombating antimicrobial resistance: policy recommendations to save livesQ24632857
Estimating health care-associated infections and deaths in U.S. hospitals, 2002Q24681642
Identification of individuals with CKD from Medicare claims data: a validation studyQ31000968
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014.Q31125434
Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA scoreQ33917987
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesQ34439990
Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysisQ35552040
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal FailureQ36461141
Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.Q36730174
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches.Q36761826
Epidemiology and outcomes of acute renal failure in hospitalized patients: a national surveyQ36910283
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsQ37537565
Acute kidney injury, mortality, length of stay, and costs in hospitalized patientsQ39730814
Incidence and Risk Factors for Colistin-Associated NephrotoxicityQ41462330
Parenteral polymyxins: assessing efficacy and safety in critically ill patients with renal dysfunctionQ42854396
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infectionsQ43203455
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectacute kidney injuryQ424337
P304page(s)ofy191
P577publication date2018-08-01
P1433published inOpen Forum Infectious DiseasesQ27725953
P1476titleThe Impact of Acute Kidney Injury on the Risk of Mortality and Health Care Utilization Among Patients Treated With Polymyxins for Severe Gram-Negative Infections
P478volume5

Reverse relations

Q64091744Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicitycites workP2860

Search more.